Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care has announced a strategic partnership with Carolinas HealthCare System’s Levine Cancer Institute and the subsequent formation of the Inivata Knowledge Accumulation Network (IKAN).
IKAN will be a global network of world-leading cancer centers working in partnership with Inivata to assess the potential of liquid biopsy to transform cancer care and improve patient outcomes.
Clive Morris, Chief Medical Officer of Inivata, said:
“We are excited to be partnering with the world-leading Levine Cancer Institute to form the Inivata Knowledge Accumulation Network. The sharing of knowledge between world-leaders is crucial for continued advancement of the field, and we anticipate IKAN will provide an efficient platform for innovative conversations and collaborations. The opportunity to continue our work with leading cancer centers on a range of clinical projects across different cancer types, will enable the swift development and validation of our InVision platform.”